BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 18431575)

  • 1. Total-body contrast-enhanced MRA on a short, wide-bore 1.5-T system: intra-individual comparison of Gd-BOPTA and Gd-DOTA.
    Rasmus M; Bremerich J; Egelhof T; Huegli RW; Bongartz G; Bilecen D
    Eur Radiol; 2008 Oct; 18(10):2265-73. PubMed ID: 18431575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective blinded evaluation of Gd-DOTA- versus Gd-BOPTA-enhanced peripheral MR angiography, as compared with digital subtraction angiography.
    Wyttenbach R; Gianella S; Alerci M; Braghetti A; Cozzi L; Gallino A
    Radiology; 2003 Apr; 227(1):261-9. PubMed ID: 12616007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimisation of a high-resolution whole-body MR angiography protocol with parallel imaging and biphasic administration of a single bolus of Gd-BOPTA: preliminary experience in the systemic evaluation of atherosclerotic burden in patients referred for endovascular procedures.
    Napoli A; Anzidei M; Marincola BC; Zaccagna F; Geiger D; Di Paolo PL; Zini C; Catalano C; Passariello R
    Radiol Med; 2009 Jun; 114(4):538-52. PubMed ID: 19430733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra-individual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for contrast-enhanced magnetic resonance angiography of the supraaortic vessels at 3 Tesla.
    Bueltmann E; Erb G; Kirchin MA; Klose U; Naegele T
    Invest Radiol; 2008 Oct; 43(10):695-702. PubMed ID: 18791411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MR angiography of the pedal arteries with gadobenate dimeglumine, a contrast agent with increased relaxivity, and comparison with selective intraarterial DSA.
    Kreitner KF; Kunz RP; Herber S; Martenstein S; Dorweiler B; Dueber C
    J Magn Reson Imaging; 2008 Jan; 27(1):78-85. PubMed ID: 18058929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Enhanced MR-angiography (CE-MRA) of the supraaortic arteries: dose reduction with a contrast agent of high relaxivity (Gd-BOPTA)].
    Friese S; Klose U; Kastrup A; Krapf H; Küker W
    Rofo; 2003 Oct; 175(10):1363-7. PubMed ID: 14556105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Gd-BOPTA and Gd-DOTA for peripheral CE-MRA: a double-blind clinical study.
    Lohr HA; Froehlich JM; Pfyffer M; Bader CW; Zollikofer CL; Wentz KU
    Acad Radiol; 2002 Aug; 9 Suppl 2():S421-4. PubMed ID: 12188295
    [No Abstract]   [Full Text] [Related]  

  • 8. 3.0 Tesla high spatial resolution contrast-enhanced magnetic resonance angiography (CE-MRA) of the pulmonary circulation: initial experience with a 32-channel phased array coil using a high relaxivity contrast agent.
    Nael K; Fenchel M; Krishnam M; Finn JP; Laub G; Ruehm SG
    Invest Radiol; 2007 Jun; 42(6):392-8. PubMed ID: 17507810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gd-BOPTA: "the MRA contrast agent of choice"?
    Fellner F; Janka R; Fellner C; Dobritz M; Lenz M; Lang W; Bautz W
    Rontgenpraxis; 1999; 52(2):51-8. PubMed ID: 10431568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of contrast-enhanced magnetic resonance angiography (MRA) using Gd-DOTA compared with time-of-flight MRA in the diagnosis of clinically significant non-coronary arterial disease.
    Kang JW; Lim TH; Choi CG; Ko GY; Kim JK; Kwon TW
    Eur Radiol; 2010 Aug; 20(8):1934-44. PubMed ID: 20407903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of meglumine gadoterate-enhanced MR angiography (MRA) compared with time-of-flight MRA in the diagnosis of clinically significant non-coronary arterial disease: a pooled analysis of data from two clinical trials.
    Shah DJ; Lim TH
    Br J Radiol; 2012 May; 85(1013):596-605. PubMed ID: 22167518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance coronary angiography: comparison between a Gd-BOPTA- and a Gd-DTPA-enhanced spoiled gradient-echo sequence and a non-contrast-enhanced steady-state free-precession sequence.
    Nassenstein K; Breuckmann F; Hunold P; Barkhausen J; Schlosser T
    Acta Radiol; 2009 May; 50(4):406-11. PubMed ID: 19308763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRA of the carotid arteries.
    Thurnher SA
    Eur Radiol; 2005 Dec; 15 Suppl 5():E11-6. PubMed ID: 18637226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast-enhanced magnetic resonance angiography: evaluation of the high relaxivity low diffusible gadolinium-based contrast agent P846 in comparison with gadoterate meglumine in rabbits at 1.5 Tesla and 3.0 Tesla.
    Peldschus K; Hamdorf M; Robert P; Port M; Graessner J; Adam G; Herborn CU
    Invest Radiol; 2008 Dec; 43(12):837-42. PubMed ID: 19002055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of Gd-BOPTA and Gd-DOTA for contrast-enhanced MRI of intracranial tumours.
    Colosimo C; Knopp MV; Barreau X; Gérardin E; Kirchin MA; Guézénoc F; Lodemann KP
    Neuroradiology; 2004 Aug; 46(8):655-65. PubMed ID: 15205859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gadobenate dimeglumine (Gd-DTPA) vs gadopentetate dimeglumine (Gd-BOPTA) for contrast-enhanced magnetic resonance angiography (MRA): improvement in intravascular signal intensity and contrast to noise ratio.
    Pediconi F; Fraioli F; Catalano C; Napoli A; Danti M; Francone M; Venditti F; Nardis P; Passariello R
    Radiol Med; 2003; 106(1-2):87-93. PubMed ID: 12951555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole-body MR angiography: first experiences with the new TimCT technology with single contrast injection.
    Naguib NN; Bohrt K; Nour-Eldin NE; Schulz B; Tawfik AM; Siebenhandel P; Bodelle B; Eichler K; Moritz A; Vogl TJ; Zangos S
    J Magn Reson Imaging; 2014 Feb; 39(2):434-9. PubMed ID: 23681601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-dimensional multiphase time-resolved low-dose contrast-enhanced magnetic resonance angiography using TWIST on a 32-channel coil at 3 T: a quantitative and qualitative comparison of a conventional gadolinium chelate with a high-relaxivity agent.
    Giesel FL; Runge V; Kirchin M; Mehndiratta A; Gerigk L; Corell B; von Gall C; Kauczor HU; Essig M
    J Comput Assist Tomogr; 2010; 34(5):678-83. PubMed ID: 20861769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial delayed enhancement using a single dose (0.1 mmol/kg) of gadobenate dimeglumine: contrast resolution versus intraventricular blood and viable myocardium.
    Papini GD; Tritella S; Secchi F; Aliprandi A; Di Leo G; Sardanelli F
    Radiol Med; 2010 Aug; 115(5):693-701. PubMed ID: 20221713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crossover comparison of ferumoxytol and gadobenate dimeglumine for abdominal MR-angiography at 3.0 tesla: Effects of contrast bolus length and flip angle.
    Schubert T; Motosugi U; Kinner S; Colgan TJ; Sharma SD; Hetzel S; Wells S; Campo CA; Reeder SB
    J Magn Reson Imaging; 2017 Jun; 45(6):1617-1626. PubMed ID: 27862577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.